PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast

Joseph M. Coney, MD, FACS, FASRS - Eye on Equity: A Comprehensive Approach to DR/DME Care in Under-Represented Populations

Professor Melanie Davies - Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management

Professor Carel le Roux, MBChB, FRCP, FRCPath, PhD / Donna H. Ryan, MD, FTOS - Adopting Modern Management Strategies for Obesity: Treating the Patient, Not the Disease

Angela Fitch, MD, FACP, FOMA - Breaking Through Biases in Obesity Management: Building Competence, Creating Connections, and Empowering Leaders in Primary Care

Lucia M. Novak, MSN, ANP-BC, BC-ADM - Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity

Professor Melanie Davies - Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes

Vanita R. Aroda, MD - Intensifying Treatment for Type 2 Diabetes According to Current Guidelines: An Office Hours Activity

Javed Butler, MD, MPH, MBA / Muthiah Vaduganathan, MD, MPH - Experts vs AI: Exploring New Paradigms in Comprehensive Care for Cardio-Renal-Metabolic Diseases

Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity

Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes

John E. Anderson, MD - Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal

P. Barton Duell, MD - Lipid Management Beyond Statins: Early Screening, Prompt Intervention, and Timely Intensification With PCSK9-Targeted Therapies

Javier Morales, MD, FACP, FACE - Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People with T2DM

Javier Morales, MD, FACP, FACE - Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal

R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management

Professor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS - Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey

Stefano Del Prato, MD - Tools of the Trade: Prioritising Weight Management in People With Type 2 Diabetes – Sharpening Your Skills to Intensify Therapy and Engage in Shared Decision-Making

Javier Morales, MD, FACP, FACE / Jay H. Shubrook, DO, FAAFP, FACOFP - Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People With T2DM

Hiddo J.L. Heerspink, PhD, PharmD / Prof. Dr. med Christoph Wanner - Chronic Kidney Disease in Patients With Type 2 Diabetes: The Impetus for Early Recognition and Strategies for Coordinating Optimal, Patient-Centered Care

Richard Keen, PhD, FRCP, Edna E. Mancilla, MD - Can YOU Avoid Iatrogenic Harm? Understanding and Identifying Fibrodysplasia Ossificans Progressiva

Jaime Almandoz, MD, MBA, FTOS - Leading the Charge to Change the Obesity Narrative: Supporting Primary Care to Improve Weight Management Discussions, Diagnosis, and Decisions

Kara Mayes, MD, FAAFP / Jay H. Shubrook, DO, FAAFP, FACOFP - Now Is the Time to Overcome Therapeutic Inertia in T2D to Achieve Personalized Glycemic and Weight Management Goals

Bradley S. Miller, MD, PhD - Improving Outcomes in Pediatric Growth Hormone Deficiency With Effective Diagnosis and Personalized Management Strategies

Athena Philis-Tsimikas, MD - Episode 4: Exploring Therapeutic Potential of Once-Weekly Basal Insulin Therapy

Donna H. Ryan, MD, FTOS -Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity

James R. Gavin III, MD, PhD - The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects

Vanita R. Aroda, MD - Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM

Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS - Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy

James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA - Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies

Professor Kausik Ray - Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD

George L. Bakris, MD - Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists

Jay H. Shubrook, DO, FAAFP, FACOFP - Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy

Jennifer I. Lim, MD, FARVO - A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy

Marcia S. Brose, MD, PhD - A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes

George L. Bakris, MD - Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists

Javed Butler, MD, MPH, MBA - Making the Case for Treating Iron Deficiency in Patients With Heart Failure

Steven Fishbane, MD - Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes

Richard Beaser, MD - Highlighting the Vital Role of Primary Care in Identifying and Optimizing the Treatment of Diabetic Retinopathy and Diabetic Macular Edema

J. Fernando Arevalo, MD, PhD, FACS - Seeing the Importance of the Timely Recognition and Treatment of Diabetic Retinopathy and Diabetic Macular Edema

George L. Bakris, MD - Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC - The Art of Medicine: Creating Treatment Regimens With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM

Ken Fujioka, MD - Leveraging the Tools at Hand: Current Perspectives on Weight-Loss Pharmacotherapy for Obesity Management

Gregory W. Albers, MD - Large Hemispheric Infarction: Exploring the Latest Clinical Advances in the Diagnosis and Treatment

John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases

Javed Butler, MD, MPH, MBA - Strategies for Increasing Recognition and Diagnosis of Patients With Heart Failure: Evaluating the Role of Natriuretic Peptides As Clinical Biomarkers

Vanita R. Aroda, MD - Test Your Knowledge: Current Guidance on GLP-1 Receptor Agonists to Individualize Treatment for T2DM

Robin Lachmann, MD, PhD / Melissa Wasserstein, MD - Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficienc

Pablo F. Mora, MD, FACE, CDE - Go Get the Glucagon! Current and Emerging Options for Treating Severe Hypoglycemia

Rohit Loomba, MD, MHSc - Navigating Diagnosis and Examining the Data: The Clinical Potential of Novel Therapeutic Strategies to Improve Nonalcoholic Steatohepatitis Outcomes

Jerry Vockley, MD, PhD - Novel Strategies and Emerging Evidence to Address Unmet Needs in Treating Patients With Long-Chain Fatty Acid Oxidation Disorders